Ranmali Ranasinghe
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- Antioxidant Activity and Oxidative Stress
Papers in
- Oncology 5
- Chemokine receptors and signaling 3
-
- T-cell and B-cell Immunology 2
- IL-33, ST2, and ILC Pathways 2
- Co-authors
- Michael L. Mathai (6 shared papers)Anthony Zulli (6 shared papers)Rajaraman Eri (5 shared papers)Mohammed Abdullah Alshawsh (1 shared paper)Agampodi Promoda Perera (1 shared paper)Madhur D. Shastri (1 shared paper)Ruchira Fernando (1 shared paper)Dharshana Kasthurirathna (1 shared paper)
In The Last Decade
Ranmali Ranasinghe
10 papers receiving 314 citations
Peers
Comparison fields: 5 of 88
- Immunology 64
- Biochemistry 18
- Oncology 74
- Pathology and Forensic Medicine 36
- Cancer Research 25
Countries citing papers authored by Ranmali Ranasinghe
This map shows the geographic impact of Ranmali Ranasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranmali Ranasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranmali Ranasinghe more than expected).
Fields of papers citing papers by Ranmali Ranasinghe
This network shows the impact of papers produced by Ranmali Ranasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranmali Ranasinghe. The network helps show where Ranmali Ranasinghe may publish in the future.
Co-authors
The 8 scholars most cited alongside Ranmali Ranasinghe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 102 | |
| 2 | 2018 | 55 | |
| 3 | 2022 | 41 | |
| 4 | 2018 | 37 | |
| 5 | 2023 | 35 | |
| 6 | 2022 | 29 | |
| 7 | 2018 | 9 | |
| 8 | 2018 | 8 | |
| 9 | 2024 | 4 | |
| 10 | 2020 | 2 | |
| 11 | 2026 | 0 | |
| 12 | 2021 | 0 |
About Ranmali Ranasinghe
Ranmali Ranasinghe is a scholar working on Oncology, Immunology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 12 papers that have together received 322 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), T-cell and B-cell Immunology (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Inflammatory Bowel Disease (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Coenzyme Q10 studies and effects (1 paper) and Artificial Intelligence in Healthcare (1 paper). The work is most often cited by research in Immunology (64 citations), Biochemistry (18 citations), Oncology (74 citations), Pathology and Forensic Medicine (36 citations) and Cancer Research (25 citations). Ranmali Ranasinghe has collaborated with scholars based in Australia, Sri Lanka and Malaysia. Frequent co-authors include Michael L. Mathai, Anthony Zulli, Rajaraman Eri, Mohammed Abdullah Alshawsh, Agampodi Promoda Perera, Madhur D. Shastri, Ruchira Fernando and Dharshana Kasthurirathna. Their work appears in journals such as Heliyon, BioFactors, Frontiers in Endocrinology, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.